Arpida Ltd and Evolva SA have announced plans to merge to create a larger, publicly-listed biotechnology company with a pipeline of drug candidates as well as revenue-generating discovery partnerships. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
